FM
ZBH icon

Foster & Motley’s Zimmer Biomet ZBH Stock Holding History

Foster & Motley’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Sell
3,011
-204
-6% -$18.7K 0.01% 364
2025
Q4 		$289K Sell
3,215
-252
-7% -$23.9K 0.02% 347
2025
Q3 		$342K Buy
3,467
+1,111
+47% +$110K 0.02% 331
2025
Q2 		$215K Buy
+2,356
New +$228K 0.01% 380
2024
Q2 		– Sell
-1,931
Closed -$255K – 399
2024
Q1 		$255K Sell
1,931
-478
-20% -$59.7K 0.02% 355
2023
Q4 		$293K Sell
2,409
-473
-16% -$52.8K 0.02% 328
2023
Q3 		$323K Buy
+2,882
New +$366K 0.03% 312

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foster & Motley's ZBH Position: Q1 2026 in Review

Foster & Motley reduced its Zimmer Biomet (ZBH) stake by 6.3% in Q1 2026, selling an estimated $18.7K and leaving 3,011 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #364.

Foster & Motley first reported a position in ZBH in Q3 2023 and has held it in 7 quarters since. The position peaked at $342K in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Foster & Motley held 3,011 shares of Zimmer Biomet worth $272K as of Q1 2026.
  • Foster & Motley sold 204 Zimmer Biomet shares in Q1 2026, an estimated $18.7K.
  • Zimmer Biomet made up 0.01% of Foster & Motley's portfolio in Q1 2026, its #364 holding.
  • Foster & Motley first reported a position in Zimmer Biomet in Q3 2023 and has held it in 7 quarters since.
  • Foster & Motley's Zimmer Biomet position peaked at $342K in Q3 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.